Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $973.79 million. The enterprise value is $775.61 million.

Market Cap	973.79M
Enterprise Value	775.61M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MLYS has 64.88 million shares outstanding. The number of shares has increased by 22.76% in one year.

Current Share Class	64.88M
Shares Outstanding	64.88M
Shares Change (YoY)	+22.76%
Shares Change (QoQ)	+6.42%
Owned by Insiders (%)	1.89%
Owned by Institutions (%)	57.13%
Float	42.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.91
P/TBV Ratio	5.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-48.50%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$3.70M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.02% in the last 52 weeks. The beta is -0.31, so MLYS's price volatility has been lower than the market average.

Beta (5Y)	-0.31
52-Week Price Change	+11.02%
50-Day Moving Average	13.90
200-Day Moving Average	12.38
Relative Strength Index (RSI)	55.50
Average Volume (20 Days)	662,293

Short Selling Information

The latest short interest is 6.43 million, so 9.91% of the outstanding shares have been sold short.

Short Interest	6.43M
Short Previous Month	6.09M
Short % of Shares Out	9.91%
Short % of Float	14.98%
Short Ratio (days to cover)	6.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-201.49M
Pretax Income	-90.80M
Net Income	-188.51M
EBITDA	-201.44M
EBIT	-201.49M
Earnings Per Share (EPS)	-$3.73

Balance Sheet

The company has $198.19 million in cash and n/a in debt, giving a net cash position of $198.19 million or $3.05 per share.

Cash & Cash Equivalents	198.19M
Total Debt	n/a
Net Cash	198.19M
Net Cash Per Share	$3.05
Equity (Book Value)	191.26M
Book Value Per Share	3.84
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.76%
Shareholder Yield	-22.76%
Earnings Yield	-19.36%
FCF Yield	n/a

Analyst Forecast

The average price target for MLYS is $33.00, which is 119.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.00
Price Target Difference	119.85%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a